Qorvo Awarded $24.4M NIH Contract to Scale POC Covid-19 Antigen Testing
The NIH contract through RADx helps advance the production and market launch of the Qorvo Omnia diagnostic test platform.
Read More
Search Results for: point-of-care
Qorvo Gets FDA EUA for Omnia Rapid Covid-19 Antigen Testing
The Qorvo Omnia SARS-CoV-2 Antigen Test is authorized for the qualitative detection of nucleocapsid viral antigens from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of covid-19.
Read More
Hologic to Acquire Molecular Diagnostic Company Mobidiag
Hologic has signed a definitive agreement to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million.
Read More
BioReference Laboratories Providing Covid-19 Testing for Major League Baseball
Under the agreement with MLB, BioReference will provide on-site rapid PCR point-of-care covid-19 testing to all 30 MLB teams, leveraging Mesa Biotech’s Accula System.
Read More
Fluxergy Receives CE Marking for 1-Hour COVID-19 Test
Fluxergy has obtained CE marking for its one-hour COVID-19 RT-PCR test, for use by healthcare professionals as an IVD for the detection of SARS-CoV-2.
Read More